Date Filed | Type | Description |
10/02/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
09/26/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
08/14/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
08/14/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
08/07/2023 |
3
| Cox Katharine Joan (Chief Accounting Officer) has filed a Form 3 on Guardion Health Sciences, Inc. |
07/31/2023 |
8-K
| Quarterly results |
07/05/2023 |
4
| WEINGARTEN ROBERT N (Director) has filed a Form 4 on Guardion Health Sciences, Inc.
Txns:
| Granted 334 options to buy
@ $7.78, valued at
$2.6k
|
|
07/05/2023 |
4
| Gagliano Donald A (Director) has filed a Form 4 on Guardion Health Sciences, Inc.
Txns:
| Granted 334 options to buy
@ $7.78, valued at
$2.6k
|
|
07/05/2023 |
4
| Griggs Michaela (Director) has filed a Form 4 on Guardion Health Sciences, Inc.
Txns:
| Granted 334 options to buy
@ $7.78, valued at
$2.6k
|
|
07/05/2023 |
4
| Goldstone Mark (Director) has filed a Form 4 on Guardion Health Sciences, Inc.
Txns:
| Granted 334 options to buy
@ $7.78, valued at
$2.6k
|
|
06/16/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
06/05/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
05/31/2023 |
4
| Hall Janet (CEO & President) has filed a Form 4 on Guardion Health Sciences, Inc.
Txns:
| Granted 10,000 options to buy
@ $6.01, valued at
$60.1k
|
|
05/31/2023 |
3
| Hall Janet (CEO & President) has filed a Form 3 on Guardion Health Sciences, Inc. |
05/30/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
05/16/2023 |
8-K
| Quarterly results |
05/15/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
05/01/2023 |
10-K/A
| Annual Report for the period ended December 31, 2022 [amend] |
04/20/2023 |
8-K
| Quarterly results |
04/17/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
04/03/2023 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: |
03/07/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
02/08/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
02/08/2023 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 7.5% stake in Guardion Health Sciences, Inc. |
01/24/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
01/11/2023 |
4
| Radoff Bradley Louis (10% Owner) has filed a Form 4 on Guardion Health Sciences, Inc.
Txns:
| Bought 63,983 shares
@ $6.7762, valued at
$433.6k
Bought 20,838 shares
@ $7.1948, valued at
$149.9k
Bought 18,630 shares
@ $7.3112, valued at
$136.2k
Bought 13,270 shares
@ $7.9989, valued at
$106.1k
|
|
01/11/2023 |
3
| Radoff Bradley Louis (10% Owner) has filed a Form 3 on Guardion Health Sciences, Inc. |
01/10/2023 |
SC 13G/A
| Radoff Bradley Louis reports a 19.7% stake in Guardion Health Sciences, Inc. |
01/06/2023 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits ... |
01/06/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
12/12/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
12/02/2022 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
12/02/2022 |
8-K
| Quarterly results |
11/30/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
|